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Abstract
Recently, hospitals, regulatory agencies, and insurers have renewed their focus on
improving patient care and safety. Outcomes based measures are being utilized and
hospitals are being asked to report on whether patients are being treated according to a
standard of care or a best practice guideline.
As peri-operative physicians, anesthesiologists are able to evaluate and, to a great degree,
affect the pre-operative, intra-operative, and post-operative course of a patient. However,
several barriers exist. Although best practice guidelines exist, current models to risk
stratify patients need improvement. Individual anesthesiologists currently have no
uniform way to measure patient outcomes, either in an institutional or provider specific
manner, and many treat patients based on anecdotal experience rather than on evidence
based medicine.
We addressed these issues through development of an electronic feedback system. The
demonstration system targeted the problem of postoperative nausea and vomiting
(PONV) in the ambulatory surgery patient population. Because performance of existing
PONV risk prediction models was poor and could not be used for educational purposes,
we created a new PONV risk prediction model and compared it against existing models.
The new, improved risk prediction model was incorporated into an electronic system that
gathered patient outcomes data related to best care practice and then fed back the
information to care providers.
After implementation of the electronic feedback system, we evaluated its efficacy in
improving compliance with best care practices.
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1 Introduction
Recently, there has been a renewed focus on improving patient care and safety. Patients,
the government, and HMOs are asking that healthcare resources be used more efficiently
to provide better quality care and care that is safer. As proof of improvement in care,
outcomes based measures are being utilized and the concept of a "balanced performance
score card" has emerged; that is, a report indicating that a hospital or physician is treating
patients according to a standard of care or a best practice guideline known to have a
positive effect on patient quality and efficiency of care.
As peri-operative physicians, anesthesiologists intensively monitor multiple parameters
related to the well-being of their patients. Because they are responsible for almost all
decisions regarding administration of peri-operative medicines, they are in the unique
position of being able to evaluate and, to a great degree, affect the pre-operative, intra-
operative, and post-operative course of a patient. However, individual anesthesiologists
currently have no uniform way to measure patient outcomes, either in an institutional or
provider specific manner, and many treat patients based on anecdotal experience rather
than on evidence based medicine (Cabana, et al., 1999). We hypothesize that a peri-
operative patient outcomes feedback system may help satisfy these deficiencies. Such a
system would identify practices that result in best patient outcomes and provide useful
feedback to care providers about their patients' outcomes and level of satisfaction. If
integrated into the educational system, it would also allow modification of provider
behavior towards compliance with best practices (Cohen, et al., 1996) (Lobach, et al.,
1997) (Shiffman, et al., 1999).
Although a few institutions are monitoring patient outcomes (Sandrick, 1998) and have
had good success with these systems (Wachter, 2001), none provides feedback to
anesthesiologists in a practice specific manner or in an automated, "real-time" manner.
Furthermore, although people have examined behavior modification in other fields of
medicine (Stomberg, et al., 2003) (Wachter, 2001), only a handful of studies in the field
of anesthesiology exist. A few indicate a positive response to feedback (Cohen, et al.,
1996) (Overdyk, et al., 1999) (Rose, et al., 1997); however, these studies do not
implement sustainable and cost effective ways of providing feedback.
2 Objectives
This study's primary objective was to develop and evaluate a sustainable electronic peri-
operative patient outcomes feedback system for its effectiveness in increasing
anesthesiologist compliance with best care practices.
Postoperative nausea and vomiting (PONV) control in ambulatory surgery patients has
been chosen as the best care practice to implement and evaluate in this demonstration
system. PONV has been chosen because it is frequent in the surgical population, has
been studied extensively (McQuay, et al., 1998) (Pavlin, 2002) (Moiniche, 2002), and
efficacy of multi-modal and risk directed treatment techniques has been demonstrated
(McQuay, et al., 1998) (Philip, 2002). Furthermore, a preliminary study in Brigham and
Women's Hospital (BWH) day surgery patients indicates that providers seldom use a
multi-modal technique for PONV prophylaxis and that treatment is not specific for
patient risk factors (Sarin, et al., 2006).
The system we developed had electronic educational materials that include a physician's
practices, their patients' outcomes, a tool to predict patient PONV risk, and current
literature recommendations. Evaluation of the system was conducted through a
prospective study examining physician practicing behavior.
In summary, this demonstration system:
1. monitored provider practice of a multi-modal PONV control regimens
2. monitored the patient outcomes of PONV in the immediate postoperative
recovery period and after discharge
3. developed, validated, and utilized a new PONV risk prediction model
4. fed back PONV risk model predictions, physician practices, patient outcomes,
and other educational materials to patient's care providers via a secure,
confidential electronic system
5. monitored change in provider behavior based on this feedback.
3 Background and prior work
Postoperative nausea and vomiting (PONV) and postoperative pain are the top two
complications in ambulatory surgery patients. Although both can significantly delay
discharge, patients are more concerned about having PONV and are willing to pay up
$100 out of pocket to prevent PONV (Gan, et al., 2001). Furthermore, having PONV
decreases patient satisfaction immensely and increases the risk of a costly overnight
hospitalization by three to four times (Habib, et al., 2004). With the number of
ambulatory surgery cases increasing each year, PONV is considered the "big little
problem" and much research into this complication has been conducted over the last 30
years. Unfortunately, the incidence has remained around 25-30% despite changes in
anesthetic practices (Palazzo, et al., 1984), possibly due to the multi-factorial nature of
PONV. At BWH, a preliminary study indicated that the overall PONV rate was 25%,
with the rate being as high as 65% in high risk patient groups (Sarin, et al., 2006).
3.1 Best practices for control of postoperative nausea and
vomiting
Several regimens have been shown to reduce the incidence of PONV in the
ambulatory surgery population. These regimens include avoiding inhalational agents
for general anesthesia (GA); providing regional anesthesia (RA) to avoid use of
narcotics that are emetogenic; and/or providing prophylactic anti-emetics in an
attempt to decrease the probability of PONV (Gan, et al., 2003) (Apfel, et al., 2002).
Each of these regimens has been shown to be effective, but not guaranteed to
eliminate PONV (Habib, et al., 2004). However, blindly applying these regimens to
all ambulatory surgery patients is neither practical nor in the patient's best interests.
Providing RA may be associated with increased time of getting the patient ready for
surgery as well as serious complications associated with the technique. Avoiding
inhalational agents for GA may raise the incidence of intra-operative awareness.
Prophylactic use of anti-emetics increases the risk of having medication related side
effects (Tramer, 2001) and is not 100% effective in preventing PONV (Domino, et
al., 1999). All three factors increase the cost of anesthesia to the patient and the
health care system as a whole (Watcha, 2000).
The current strategy for reducing PONV relies on risk stratifying the patient and then
tailoring treatment based on the classification. For example, in one system, patients
considered to be at extremely high risk are recommended to receive multiple anti-
emetics as well as avoidance of GA and narcotics if possible, whereas patients
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considered to be at low risk are recommended to receive no prophylaxis and only be
treated ifPONV develops (Figure 1) (Gan, et al., 2003) (Gan, 2006). The specific
best practices used for the electronic feedback system of this project are shown in
Table 1 and are based on the above strategy of risk stratifying patients.
Figure 1: Guidelines for PONV prophylaxis (Gan, et al., 2oo3).
Risk group Recommendations
Low risk Zero prophylactic anti-emetics; judicious use of narcotic as defined by fentanyl
<=100 mccq IV given at end of case
Medium risk Two prophylactic anti-emetics, but not ondansetron; judicious use of narcotic as
defined by fentanyl <= 100 mcq IV given at end of case
High risk Three or more prophylactic anti-emetics; avoidance of nitrous oxide; judicious use of
narcotic as defined by fentanyl <= 100 mcg IV given at end of case
Extremely Three or more prophylactic anti-emetics; avoidance of nitrous oxide and inhalational
high risk agents; judicious use of narcotic as defined by fentanyl <= 100 mcg IV given at end
of case
Table 1: Best practices used for electronic feedback system
3.2 Risk models for PONV
Many models have been developed to classify patients into risk groups.
Unfortunately, the current models cannot be effectively used for any decision support
purposes and are too simple for the educational purposes of this project. Even the
"best" models do not have great discriminatory ability in predicting PONV. They
cannot be used for decision support beyond risk stratifying patients based on patient
history, as they include only non-modifiable factors and rather than factors that the
physician can control. Furthermore, they cannot be used to educate anesthesiologists
about practices that can potentially reduce a patient's risk of PONV. Although
reasons for simplification of the original models were valid (Apfel, et al., 1999)
(Apfel, et al., 2002) when the models were first developed, it should now be possible
to apply improved yet more complex models to predict PONV risk from information
derived from anesthesia management systems that are routinely utilized in the care of
patients.
One of the first models for risk assessment of PONV was developed by Palazzo and
Evans. This model was created using logistic regression to identify variables
associated with increased PONV in patients undergoing orthopedic surgery (Palazzo,
et al., 1993). Since then, models have been created using data from patients
undergoing a greater variety of surgical procedures. Of these, the scoring systems of
Apfel (Apfel, et al., 1999) and Koivuranta (Koivuranta, et al., 1997) are best known.
Both used logistic regression on data from inpatients undergoing a number of
different procedures and recorded the outcome of PONV up to 24 hours after surgery.
Although the models considered patient history (e.g., sex, history of PONV, history
of motion sickness), intra-operative factors (e.g., medications given, fluids
administered) and surgical factors (e.g., type of surgery, duration of surgery), both
Apfel and Koivuranta decided to use the top few variables in order to simplify the
final models.
Figure 2: Models published that predict risk of PONV
Apfel's final model (Figure 2a) only included three patient history factors and
postoperative narcotic use in order to predict PONV. Koivuranta's model (Figure 2b)
used the same factors except it replaced postoperative narcotic use with duration of
surgery over 60 min (Koivuranta, et al., 1997). This simplification of the models was
justified by the fact that final score's accuracy, as measured by the Area Under the
Curve, was not significantly affected and was considered to be more clinically
a. Original Apfel model (Apfel, et al., 1999):
logit(p)= -2.28+1.27* femalegender+ 0.65* (PONVHxor MSHx)
+ 0.72* (1- smokingHx} 0.78* postopNardJse
b. Koivuranta model (Koivuranta, et al., 1997):
logit(p)= -2.21+ 0.93* femalegender+ 0.82* PONVHx+ 0.59* MSHx
+0.61* (1-smokingHxi-0.75*durationof surgeryover60 min
c. Simplified Apfel risk score (Apfel, et al., 1999):
* Predictors are female gender, history of PONV or motion sickness, smoking history,
postoperative narcotic use
Number predictors Risk (%)
present
0 10
1 20
2 40
3 60
4 80
d. Sinclair model (Sinclair, et al., 1999):
logit(p) = - 5.97-0.14* Age - 1.03* Sex - 0.42* SmokingHx
+ 1.14* PONVHx+ 0.46* Duration+ 2.36* GA + 1.48* ENT
+ 1.77* Ophthahm+ 1.90* Plastic+ 1.20* GynNonDC+ 1.04* OrthKnee
+ 1.78* OrthShouldbr + 0.94* OrthOther
applicable (Apfel, et al., 2002). Apfel developed a simplified PONV risk score based
on these four predictors and the predicted risk of PONV for the simplified Apfel risk
score is shown in Figure 2c (Van den Bosch, et al., 2005). Because these models
were based on data from inpatients and not applicable to ambulatory surgery patients,
Sinclair analyzed data from over 17,000 ambulatory surgery patients. He published a
model (Figure 2d) that noted that the type of surgery, type of anesthesia, and certain
patient history factors were important in predicting PONV (Sinclair, et al., 1999).
Discrimination of the Apfel and Koivuranta models have been evaluated in outside
centers. In the derivation center, AUCs were 0.75 and 0.72, respectively, using
independent test sets. In validation datasets at other centers, the AUCs have ranged
from 0.63-0.68 for Apfel's model, and 0.66-0.70 for Koivuranta's model (Van den
Bosch, et al., 2005) (Apfel, et al., 2002). Sinclair's model has not been validated in
an external center but showed an AUC of 0.78 in the study's test set (Sinclair, et al.,
1999).
3.3 Compliance with recommended PONV practices
Although PONV has been studied extensively and guidelines have been published in
the literature, compliance with recommended practices by anesthesiologists is low.
Pilot data from BWH indicate overall compliance with recommended practices is less
than 50% and that compliance with recommended best practices in high risk patient
groups is less than 10%. When surveyed, anesthesiologist provide several reasons for
non-compliance. For one, they feel that they do not have the time to follow-up on all
of their patients to see what their outcomes were or to provide some of the more
aggressive preventative treatments. They may only follow-up on a select group of
patients and this may result in a "selection bias." Furthermore, because of a lack of
recorded data, many physicians feel that their patients do not have bad outcomes.
Other physicians provide all patients with aggressive treatment, without regard to
risks or costs associated with the treatment.
A few institutions are monitoring patient outcomes (Sandrick, 1998) and have had
good success with feedback systems (Wachter, 2001) (Stomberg, et al., 2003). Most
examine behavior modification in other fields of medicine and only a handful of
studies in the field of anesthesiology exist. A few in this field indicate a positive
response to feedback (Wachter, 2001) (Cohen, et al., 1996) (Overdyk, et al., 1999)
(Pierre, et al., 2004). However, these studies do not implement sustainable and cost
effective ways of providing feedback over long periods.
Cohen first examined if feedback can affect anesthesiologists' practice patterns. The
group provided individualized feedback and education to anesthesiologists with
regards to PONV control practices over a two year period with a control group
receiving no feedback. The individualized feedback included information on number
of promoted measures with which they complied and the individual's PONV rate.
The group noticed an increase in compliance with PONV control practices during the
study period but, unfortunately did not examine for continued compliance after
feedback was stopped (Cohen, et al., 1996). Overdyk also examined PONV control
practices in anesthesiologists. His study posted monthly bar charts comparing
incidence of PONV, number of patients receiving practices, and patient satisfaction
between attendings. Educational literature was also posted. Feedback and literature
were discussed during staff meetings each month. The study noted more appropriate
prescribing of prophylactic medications and decrease in medication cost without any
increase in PONV or decrease in patient satisfaction (Overdyk, et al., 1999).
These studies provided paper based feedback that is costly to create, disseminate, and
requires continued effort to maintain. They did not elucidate strategies to provide
feedback to anesthesiologists in a practice specific manner, in an automated, "real-
time" manner that is sustainable over time.
To the best of our knowledge, no study has evaluated the impact of automated
electronic feedback to anesthesiologists and effects on change in practice compliance.
4 Design & Implementation
4.1 Overview
In order to meet the goals of this project, the following informatics infrastructure was
put into place:
1. A clinical database and web based front end that allows entry of clinical
data found in the patient record by a care provider or a research assistant.
2. A departmental research database that transforms clinical data into data
that are easier to use for research purposes.
3. Web based electronic feedback components that can be used by physicians
to analyze their own practices and patient outcomes.
At BWH, patient charts are in paper format. To maximize collection of research data,
most information recorded on a paper chart was transferred to this specialized
research database. These data include various patient history factors, type and mode
of intubation, medications given (including inhalational agents, carrier gas flow rates,
and vasopressors), and complications in O.R. Recovery room data collected include
pain scores recorded every 20 minutes, outcomes of nausea/vomiting recorded every
20 minutes, analgesic and anti-emetic medications given, times in each phase of
recovery, and time to discharge. These data are collected on ambulatory surgery
patients undergoing breast biopsies, diagnostic laparoscopy, laparoscopic procedures,
or herniorraphy. Surgery start and end times are provided electronically by Partners
Information Systems and combined with the above data. Descriptions of all data
collected are listed in Table 2.
Clinical data are entered into the system at the point of care using a tablet PC. The
data are stored in a local database; at the end of the day, this local database is
synchronized with a database on a remote server. On the remote server, clinical data
are transformed and copied into the research database.
From this data, PONV risk models specific to BWH and ambulatory surgery patients
have been created and internally validated. These models are used as part of the
electronic system to provide physicians feedback on how their decisions might affect
PONV risk.
After the physician treats five new patients, an HTML e-mail containing physician
practices and patient outcomes is generated and sent to the physician. These data, as
well as detailed statistics, literature, and the PONV calculator created from the risk
models, are also available to physicians via a secure web site. All activity is logged,
including whether an e-mail has been read and how much time the physician has
spent on each part of the web site.
This electronic feedback system uses web based technologies to maximize
availability. The front end to the system is any HTML compliant web browser with
Javascript. The back end server technology uses the Adobe ColdFusion application
server programming language that dynamically generates HTML. The Apache web
server is used to serve the HTML created to clients. Postgresql is used as the
database server to store all data.
Group Data Element Valid Responses Comments
Demographics Name From Partners I/S
and Case MRN From Partners I/S
Information DOB (age) From Partners I/S
Sex M, F From Partners I/S
Operation / type of From Partners I/S
surgery
Surgical service From Partners I/S
Anesthesia attending From Partners I/S
Anesthesia resident From Partners I/S
History Home medications List of relevant
medications
History of PONV Yes, no, unknown
History of motion Yes, no, unknown
sickness
Smoking history Yes, no, unknown
ASA Class I II, III, IV
Preoperative Medications List with dosage
Intraoperative Medications List with dose & time of Include inhalation agent;
administration include N20, air, 02 with
flows
Type of anesthetic GA, MAC, RA, unknown
If GA, type of airway Mask, LMA, ETT, unknown
If GA, type of induction IV, inhalational, unknown
If GA, induction agent Propofol, STP, sevoflurane, other,
unknown
If GA, maintenance agent IV, sevoflurane, desflurane,
isoflurane, unknown
Local anesthetic used by Name and amount, none, unknown
surgeon
Fluids administered Type and volume
Estimated Blood Loss
(EBL)
Duration of surgery From Partners I/S
Phase 1 Medications List with dosage
Recovery and Incisional pain 0-10 Every 20 minutes
Phase 2 Nausea 0-10 Every 20 minutes
Recovery Vomiting Yes, no, unknown Every 20 minutes
Time of arrival
Overall Time in Phase 1 Calculated
Recovery Time in Phase 2 Calculated
Overall recovery time Calculated
Table 2: Data collected from patient chart for research purposes
4.2 Database Development
4.2.1 Overview
Postgresql is used to store all data required for the application. Postgresql is a
free, multi-environment and well developed SQL relational database. Two
databases were designed - the first to store clinical data and the second to
store processed research data.
4.2.2 Clinical database
Clinical data are stored in a schema containing seven tables. These tables are
normalized to comply with relational database standards and therefore do not
store the same data in multiple locations nor store derived data. All tables are
linked via foreign keys and all have primary keys. The schema is shown in
Figure 3; tables in the database are listed in Table 3.
Figure 3: Schema of clinical database and relationships between tables. See text for more
detailed description.
Table Name Description
caseinfo Primary table containing case information
demo Patient demographics
history Patient history
anestype Type of anesthesia performed for case
recovery Recovery room course for case
meds Medications administered to patient preoperatively, intraoperatively, or
postoperatively
scores Pain, nausea, and vomiting scores postoperatively
medinfo Supporting table, linked to table "meds" to identify medications
anesstaff Supporting table, linked to table "caseinfo" to identify anesthesia staff
associated with case
Table 3: Tables in clinical database. See text for more detailed description.
The two primary tables are "caseinfo" and "patinfo". Table "caseinfo" stores
data related to the actual case, such as date of surgery, surgery description,
starting and ending times, anesthesiology staff, etc. The "caseid" is the
primary key and a unique id for each case. The "patid" foreign key links this
table to table "demo" such that identifying patient information is stored
separately of case information. Table "caseinfo" also contains fields to
indicate whether a case will be used in the evaluation study or not; the field
"active" is modified by a program to eliminate ambulatory cases that are not
part of the evaluation study and field "stageid" is used to indicate whether all
relevant case information has been captured.
All other tables are linked to table "caseinfo" via the unique foreign key
"caseid". Table "anestype" contains information on type of anesthesia
performed, such as general anesthesia versus monitored anesthesia care, type
of airway used, etc. Table "history" stores data on patient history factors,
such as whether the subject has had PONV in past, history of motion sickness,
height, weight, etc. Table "meds" stores all medications the patient receives
peri-operatively. The table provides for a record of when a medication is
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started and ended, as well as the dose given. Table "recovery" contains fields
for data collected in the recovery room, such as when patients arrive to the
recovery room, when they are ready for discharge, any complications, etc.
Table "scores" contains fields recording nausea/vomiting scores, incisional
and non-incisional pain scores, sedation scores, as well as their times.
Descriptions of each table are listed in Table 3 and information on the fields
they contain are in Table 2.
4.2.3 Research database
The second schema contains data in a format that is more suitable for research
purposes; this is done for performance reasons so that statistics can be
compiled on-the-fly. Once a day, a ColdFusion program examines the clinical
database for updated information and then processes, transforms, and stores
the new data in the research database. Two tables are used to store these data.
Table "dsudatastaffid" stores associations between cases ("caseid") and the
provider ("staffuserid"), as well the number case for that provider
("staffcasenum"). These data were used to determine how many cases a staff
member had done by a given date and to determine when a staff member had
completed an additional five cases such that an e-mail could be sent. Table
"dsudata" stores processed information, such as the computed field
"avgpainscorephase 1," which is the time weighted average of a patient's pain
scores in phase 1 of recovery. The table "log" kept track of various events,
including how much time a user spent reading the e-mail, when and where the
user logged in from, and how much time was spent on a particular section of
the website. Data was captured and entered into this table as described in
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section 5.5. The diagram of the schema for the research database is shown in
Figure 4.
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Figure 4: Schema of research database and relationships between tables. See text for more
detailed description.
4.3 Data capture and upload
As indicated before, infrastructure to allow electronic capture of data needed for this
project had to be created. This goal was accomplished by creating a system that
could be used by the research assistant (or, in the future, by clinicians and nurses) to
capture data at point of care in order to maximize the number of data points captured
without errors. The system presents the research assistant with the operating room
schedule for the day, filtered to show only ambulatory surgery patients who are to be
included in the study (Figure 5). Patient MRN, description of surgery, surgeon, and
time of surgery are listed for each case; patient names are only displayed when the
mouse hovers over the MRN because of patient privacy issues. Cases are grouped by
where in the recovery process the patient is in: (1) expected for arrival in the recovery
room, (2) in stage 1 of recovery, (3) in stage 2 of recovery, or (4) ready for discharge.
This type of grouping allows the user to quickly locate the patient for whom data
need to be entered.
m........ a .. S .- ........ ....
.... 
3 
.f. .. ...... 
M R......... :. • •...........-... . ........ ......
Figure 5: Research assistant screen showing all cases for which data needs to be collected. Patients were
organized by stage of recovery process.
After selecting the patient by clicking on their MRN or description of surgery, the
user is directly taken to the data that needs to be filled out. For example, if the patient
is in stage 1 of recovery, the user is automatically taken to the section allowing data
to be entered on pain scores and medications given during this stage of recovery. The
user can modify data for other sections, such as the recovery room course, by clicking
on the appropriate tab that is linked to the section (Figure 6).
1. 7ti ivecame .z' 5
Aiaw .P.yl Iti7"7
Prhnwy aneshefic IsibidUmWy t
___fL2epk-u I-
-7--- --
Figure 6: Web based system created to enter patient chart information into the database. The form to
enter information on intra-operative course is shown.
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Figure 7: Form to enter information on recovery room course.
To ease entry of data, the user is not required to click on multiple confirmation
buttons or submit multiple forms. An Asynchronous Javascript And XML (AJAX)
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programming methodology is used such that when the user enters a value in an input
box, the value is automatically saved when the input box loses focus. The input box
border changes from red to green to indicate a successful save of the data in the
database. If the server cannot be reached, or data cannot be saved for any reason, an
alert box informs the user of the error. An example of an AJAX based form is shown
in Figure 7.
As indicated before, the data are uploaded on a daily basis from the tablet PC to the
central server. Once uploaded, daily processing of the clinical data occurs and data
are transformed for storage in the research database.
4.4 Creation and validation of risk models for PONV
4.4.1 Overview
Several published risk models were considered for use in the feedback system,
but were not used because of their poor performance on preliminary data, as
well as the fact that they did not contain certain predictors. For example, no
currently published model includes the effects of prophylactic anti-emetics or
of different types of general anesthesia on PONV. Therefore, various
machine learning techniques were examined for model creation. It was
decided that a logistic regression model should be used to create an improved
predication model using the BWH data. This type of model has been explored
in anesthesiologists' literature and many physicians are familiar with it. Other
models, such as Bayesian networks and neural networks, are more difficult to
use in a clinical context and may include "black box" functions to come up
with a risk prediction score.
4.4.2 Statistical software
SAS version 9.1 (Windows platform) was used for logistic regression
modeling and analysis.
4.4.3 Data source and pre-processing
Data used for development of models were extracted from the research
database described above. The binary outcome measure was postoperative
nausea/vomiting. Based on extensive literature search and consultation with a
local domain expert (Philip, 2006), 17 of the strongest predictors were
selected for consideration in the model. Clinical data collected is listed in
Table 2. From this clinical data, the following variables were used for model
development (Table 4): age (closest decade), female sex, smoking history,
history of PONV, history of motion sickness, type of surgery, duration of
surgery (in hours), type of anesthesia provided, intraoperative dose of fentanyl
(in mcg), use of ondansestron for prophylaxis, use of dexamethasone for
prophylaxis, use of scopolamine patch for prophylaxis, use of metoclopramide
for prophylaxis (2 different doses used), use of ephedrine IM for prophylaxis,
postoperative dose of narcotics in analgesic equivalents, and maximum
postoperative pain score.
Variable Comments
Age Rounded to dosest decade
Female sex
Smoking history Patient current smoker
History of PONV History of PONV with previous surgeries
History of motion sickness
Type of surgery Breast surgery (including breast biopsy and lumpectomy)
Breast plastics surgery
Laparoscopic cholecystectomy
Hernia repairs (inguinal and other hernia)
Pelviscopy
Hysteroscopy/D&C
Duration of surgery Expected duration of surgery, in hours
Type of anesthesia provided IV induction with inhalational agent and N20 maintenance
IV induction with inhalational agent maintenance (no N20)Inhalational induction with inhalational agent and N20
maintenance
Inhalational induction with inhalational agent maintenance
(no N20)
IV induction and IV maintenance
Intraoperative dose of fentanyl Fentanyl dose used intraoperatively, in mcg
Use of ondansetron for prophylaxis Ondansetron 4 mg IV given prophylactically
Use of dexamethasone for prophylaxis Dexamethasone >6 mg IV given prophylactically
Use of scopolamine patch for prophylaxis
Use of metoclopramide = 10 mg IV for
prophylaxis
Use of metodopramide = 20 mg IV for
prophylaxis
Use of ephedrine IM for prophylaxis
Postoperative dose of narcotics In analgesic equivalents
Maximum postoperative pain score Pain score reported by patient on scale of 0-10
Table 4: Variables used for model building.
The original dataset was examined for invalid or missing values and all
patients with any invalid data were eliminated from the model building
process. Data were imported into SAS from a CSV file. Categorical variables
were reformulated as dummy variables where needed. For example, the
categorical variable of surgery type was transformed into dummy variables
with the baseline risk being for "hysteroscopy/D&C." Continuous variables
were not converted. For example, "duration of surgery" (rounded to nearest
60 minutes) and "age" (rounded to nearest decade) were left as continuous
variables. Patient history factors and the outcome variable of PONV were
considered binary variables. These transformations resulted in a total of 26
continuous and categorical variables for use in modeling.
4.4.4 Model building and analysis
Prior to model building, the data were randomly divided into a % training set
and a % test set. These two sets were compared to confirm that data had
indeed been split randomly and the frequency of the variables' values was not
significantly different. The PROC LOGISTIC function in SAS was used to
build a logistic regression model using a stepwise algorithm on the training set
with the 26 variables. Variables were entered into the model if they met a
significance level of p<0.50 and were allowed to stay in the model if they met
a significance level of p<0.20 (Shtatland, et al.). Model building stopped
when no additional variables met these criteria.
The experimental model (EM) created was compared against the original
Apfel model (OAM), a refitted Apfel model (RAM), the simplified Apfel risk
score (SARS), and a refitted Sinclair model (RSM). In order to refit the Apfel
and Sinclair models, new beta coefficients were calculated using the variables
from the original model using the PROC LOGISTIC function. Each of the
models was then run against the test data. To estimate the discriminating
power of the models, Receiver Operating Characteristic (ROC) curves were
created and the Area Under the Curves (AUC) were calculated using SAS
(Figure 13). The ROC curve allows visualization of the relationship of
sensitivity and specificity at different probability thresholds. The AUC
determines how well patients who had PONV could be distinguished from
patients who did not have PONV using the model's risk prediction
calculation. An AUC of 1.0 represents perfect discrimination whereas an
AUC of 0.5 represents no discrimination (Hanley, et al., 1982).
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Pair-wise AUC comparisons were performed to evaluate differences in
discrimination between models as described previously (DeLong, et al., 1988)
(Hanley, et al., 1983). Here, a non-parametric comparison of the ROC is
done.
Calibration curves were also developed to examine the accuracy and goodness
of fit of each model. For each model, the predicted number of observations
was plotted against the expected number of observations for each of ten risk
percentiles created from the test set. For the simplified Apfel model, it was
only possible to categorize patients into four bins. A slope of 1 with an
intercept of 0 indicates perfect calibration whereas a larger slope indicates an
over-estimation of occurrence of PONV by the model. Calibration was
further evaluated with Hosmer-Lemeshow goodness of fit X2 estimates using
deciles (Lemeshow, et al., 1982).
4.5 Electronic feedback to physicians
4.5.1 Overview
Two components were created to provide electronic feedback to physicians.
First, an electronic summary report displayed up-to-date statistics on a
physician's practices and patient outcomes as related to PONV control. These
individualized summary reports (Figure 8) were automatically e-mailed to the
physician every five patients he or she treated.
The next component created was a web site onto which physicians could login
to view details of their practices and patient outcomes (Figure 9-Figure 10).
Here, they could calculate the PONV risk of hypothetical patient using a
"PONV calculator" (Figure 11). They could also view various "what-if'
scenarios to see how change in treatment would affect patient outcome and/or
cost. Current guidelines, as well as links to current literature, were posted on
this web site.
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Figure 8: Example of summary report for PONV control that was e-mailed to physician every time
he/she completed five new cases.
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Figure 1o: Outcomes for patients treated by one physician. The physician could view details of
the case as well.
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Figure ii: Online PONV risk calculator and current guidelines. The calculator automatically
calculated risk based on patient risk factors as per the BWH PONV risk model. Current guidelines
were also listed.
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4.5.2 Programming software
Both the summary report and web site were coded in Adobe ColdFusion 7
MX markup language, a server side programming language which
dynamically generates HTML. Apache web server was used to serve the web
page to a client side web browser. A combination of HTML, Javascript, and
AJAX technologies were used, as described below, to log actions on the web
site as well as verify that e-mails were read.
4.5.3 E-mail report
These reports contained information on the physician's PONV rate and
percentile, compliance with proposed recommendations, and anesthetic costs
(Figure 8).
Upon opening and closing of the e-mail message, a message was sent to the
server log and the amount of time spent reading the message was calculated.
This was accomplished by including a hidden link to an image on the web
server. Upon opening of the HTML formatted e-mail, the mail client fetched
the image from the server via a URL that included a unique token identifying
the user. The time this image was accessed and the ID of the user accessing it
were logged into the database. Furthermore, clicking on the links in the e-
mail message was also recorded and allowed differentiation of whether the
user logged in via e-mail link or directly onto the web site.
4.5.4 Web site
The web site allowed physicians to view details of their practices and patient
outcomes. The web site was divided into multiple tabs or sections. The first
section showed the physician his or her practices in a compact table (Figure
9). Moving the mouse over the column headers provided a tooltip containing
information about how to determine the risk group of the patient. Moving the
mouse over the row headers provided tooltips on each of the different
recommended practices. Tooltips on whether the practice should be practiced
more or less often appeared when the user placed the mouse over the cell
contents.
The next section of the web site showed the physicians their patients'
outcomes (Figure 10). It allowed them to view whether they followed the
recommended guidelines, if a patient had PONV, and, if he or she did,
whether the physician might have reduced the risk by following the
recommended guidelines. Furthermore, physicians could view details on
patient history factors to learn how to place patients in the appropriate risk
group. They could also view various "what-if' scenarios to see how changes
in treatment would affect patient outcome and/or cost.
The last section contained a PONV risk calculator and educational material
(Figure 11). The anesthesiologist could use the PONV risk calculator to
calculate any patient's risk for PONV by entering some patient history factors
and her intended anesthetic plan. The calculator used Javascript to calculate a
risk score and automatically convert this into a risk probability based on the
type of surgery to be performed. The related guidelines were automatically
highlighted when the user calculates a PONV risk. Furthermore, the PONV
calculator was displayed such that the anesthesiologist could print the page
out and calculate the score manually; in fact, copy of this page and the risk
calculator was distributed to all subjects receiving feedback in the study. The
section also contained literature on PONV and the recommended guidelines.
PDF copies of several review articles were available through links on the web
page.
All activity on the web site was logged and date/time stamped. Javascript was
used to send a message to the server each time the user logged in or out or
when the user moved from one section to another. This allows tracking of the
number of times the user used the web site, whether they logged in from the e-
mail or accessed the web site directly, and calculation of the amount of time
the user spent reading each section. Similarly, each use of the PONV risk
calculator was logged, as well as each access to a PDF article.
4.5.5 Evaluation
Evaluation of the electronic feedback components was conducted using a
before-after study design with a concurrent control group. An eight-month
evaluation phase was subdivided into three stages. The first stage involved
collecting data on PONV control practices and outcomes for four months,
without any feedback to any providers, on patients undergoing breast biopsies,
diagnostic laparoscopy, laparoscopic procedures, or herniorraphy, as
described before. These data provided a baseline of provider practices as well
as patient outcomes. Prior to the second stage, each subject was randomized to
an intervention or control group. For four months, individualized feedback on
(a) practitioner's practices, and (b) outcomes for all patients was provided to
the experimental group via the electronic feedback system described before.
The control group received no feedback. Once assigned to a group, the
subject remained in that group for the duration of the study.
Attending level BWH anesthesiologists treating ambulatory surgery patients
were identified from the Dept. of Anesthesiology staff lists for potential
inclusion in the study. No remuneration was provided. There was no age
restriction on subject enrollment and there was no inclusion or exclusion of
specific groups.
A research assistant collected all data on physician practices and patient
outcomes in real time from the medical record, i.e. anesthesia pre-operative
and intra-operative records, as well as post-operative nursing records. If
information was not complete, the assistant obtained the information from
either the physician or the nurse.
Only subjects who treated more than 40 patients during each stage of the
study were included in the analyses of provider behavior, as per a power
analysis done prior to study implementation (assuming a 25% absolute change
in behavior profile, alpha = 0.05, beta = 0.10).
Outcomes measured were (a) the number of times a physician accessed the
web site, (b) the amount of time spent on each section of the site, (c) the
number of articles downloaded from the web site, and (d) the number of times
the online PONV calculator was used.
Physician practices were also examined according to recommended
guidelines. The number and type of prophylactic anti-emetics given to low,
medium, high, and extremely high risk patients were examined. According to
currently accepted guidelines, low risk patients should have been given zero
prophylactic anti-emetics; medium risk patients should be given two
prophylactic anti-emetics, but not ondansetron; high risk and extremely high
risk patients should be given three or more prophylactic anti-emetics. The
average fentanyl dose used was also examined: less than 100 mcg fentanyl
should have been given to high and extremely high risk patients. Also, N20
should have been avoided in high and extremely high risk patients and and
inhalational agents avoided in extremely high risk patients.
The percentage of each subject's patients receiving appropriate therapy, as
determined by the patient's PONV risk stratification noted above was
calculated. This was averaged by the number of subjects in the group. An
unpaired t-test was done on the group percentage to look for any significant
change in average behavior pre- and post-intervention. The rate of use of
these different profiles, stratified by PONV risk status, was compared using a
ý2 test in order to determine if there was a behavior change between the time
periods.
Subjects were also asked to complete a survey regarding the level of feedback
they were receiving about their patients, whether they wanted more feedback,
if they felt they would change their behavior based on this feedback, and
tested their knowledge about current PONV risk models (Figure 12). All
answers were on a 5 point Likert scale with five equal to "all of the time" and
zero equal to "never." They were also asked to estimate their rates of PONV.
Subjects completed this survey twice, once at the beginning of the study and
once at the end of the study.
Follow up interviews were conducted at the end of study with all participants
to query their views on the electronic feedback provided, the web site, and
reasons for changes or no changes in their practices.
The following questions refer to feedback about outcomes.
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Figure 12: Anesthesiologist survey.
5 Results
5.1 PONV risk models
Data from 2498 patients were used in the model building and testing process. The
distribution of patient, anesthetic, and surgery characteristics was not significantly
different between the training and test sets and is shown in Table 5. The experimental
model ended up containing 10 input variables, including four patient history and
outcome factors, two surgical factors, and four anesthetic factors. Patient history and
outcome factors included: age, history of motion sickness, history of PONV, and
maximum pain score postoperatively. Surgical factors included duration of surgery
and type of surgery. Types of surgery found to have significant effect on PONV were
laparoscopic cholecystectomy and pelviscopy. Anesthetic factors found to have an
effect on PONV included: intraoperative fentanyl dose, intraoperative
dexamethasone use, intraoperative ondansetron use, and type of anesthetic performed
(e.g., IV versus inhalation induction and N20 use versus no N20 use). PONV was the
binary outcome variable in the model.
The final experimental model, its beta coefficients, and odds ratios are shown in
Table 6. The strongest patient history and surgical factors increasing risk are
laparoscopic cholecystectomy, history of PONV, pelviscopy, history of motion
sickness, and duration of surgery. Anesthetic factors increasing risk included the type
of anesthetic utilized, with inhalation induction increasing risk the most. Age and use
of prophylactic ondansetron or dexamethasone reduced PONV risk.
The new beta coefficients calculated for the refitted Apfel model (RAM) and for the
refitted Sinclair model (RSM) are shown in Table 7 and Table 8.
Variable Training set Test set p value
(n=1688) (n=844)
Duration (hrs) 2.8±1.0 2.8±1.0 0.84
Surgery Type (%) 0.45
Hysteroscopy 26.2 26.4
Breast biopsy/lumpectomy 25.2 24.5
Pelviscopy/myomectomy 18.7 19.4
Inguinal and other hernia 14.8 14.8
Breast plastics 5.2 6.0
Laparoscopic cholecystectomy 5.3 3.4
Tubal ligation 3.1 3.9
Other GYN surgery 1.5 1.4
Age (decade) 4.8±1.4 4.9±1.3 0.36
Sex (% female) 88.3 87.8 0.70
Weight (kg) 69.4+14.3 69.3±14.8 0.90
History of PONV (%) 24.6 24.5 0.95
History of motion sickness (%) 31.8 33.3 0.45
Smoker (%) 10.4 11.0 0.65
Type of anesthesia (%) 0.06
IV Induction with NO 22.0 24.4
IV Induction without NO 35.1 32.0
Inhalation Induction with NO 12.1 11.4
Inhalation Induction without NO 4.8 7.3
MAC 24.5 23.1
Intraoperative ondansetron (%) 47.3 49.1 0.40
Intraoperative dexamethasone (%) 40.2 39.5 0.71
Intraoperative scopolamine (%) 17.1 17.8 0.66
Intraoperative metoclopramide =10 m (%) 55.1 54.3 0.69
Intraoperative metoclopramide >10 mg (%) 2.9 3.7 0.30
Intraoperative IM ephedrine (%) 4.6 4.2 0.59
Intraoperative fentanyl dose (mcg) 91.3±83.6 89.1+80.3 0.54
Maximum pain score in phase 1 3.3±2.4 3.2±2.5 0.19
Postoperative narcotics (analgesic equiv) 0.30±0.38 0.32±0.44 0.24
Crude PONV rate (%) 22.5 22.0 0.81
Postoperative rescue anti-emetics (number) 0.2 2±0.61 0.21 +0.58 0.96
Table 5: Distribution of patient, anesthetic, and surgery characteristics between training and
test data sets. None of the variables had statistically significant differences between these sets
(p > o.o5). p-value indicates result of Chi-square test for categorical variables or of t-test for
continuous variables.
Beta p-value Odds Ratio 95% CI
coefficient Estimate
Intercept -2.0863 <0.001
Age -0.1804 0.0005 0.835 0.754-0.924
History of PONV 0.9749 <0.0001 2.651 2.007-3.500
History of motion sickness 0.4259 0.002 1.531 1.174-1.996
Maximum postoperative pain score 0.1085 0.0002 1.115 1.053-1.180
Duration of surgery 0.1803 0.01 1.198 1.045-1.373
Surgery Type (vs "Other")
Laparoscopic cholecystectomy 1.1613 <0.0001 3.194 1.919-5.317
Pelviscopy 0.4665 0.004 1.594 1.161-2.189
Intraoperative fentanyl dose 0.002 0.02 1.002 1.000-1.004
Intraoperative dexamethasone use -0.2220 0.10 0.801 0.611-1.049
Intraoperative ondansetron use -0.1972 0.18 0.821 0.615-1.096
Anesthesia type (vs "Other") <0.0001
IV induction with nitrous oxide use 0.2924 0.09 1.340 0.951-1.887
Inhalation induction with nitrous 0.8725 <0.0001 2.393 1.547-3.700
oxide use
Inhalation induction without 0.9497 0.001 2.585 1.450-4.607
nitrous oxide use
MAC -0.8049 0.002 0.447 0.270-0.739
Table 6: Final experimental model (EM) created using logistic regression. 95% CI = 95% Confidence
Interval.
Original New beta p-value Odds Ratio 950 % CI
beta coefficient Estimate
coefficient
Intercept -2.28 -2.78 <0.0001
Female sex 1.27 0.67 0.03 1.950 1.059-3.590
History of PONV or 0.65 0.93 <0.0001 2.531 1.801-3.558
motion sickness
Non-smoker 0.72 -0.014 0.96 1.015 0.596-1.726
Postoperative narcotic 0.78 0.73 <0.0001 2.072 1.438-2.988
use
Table 7: Beta coefficients and odds ratios for refitted Apfel model. 95% CI = 95% Confidence Interval.
Original New beta p-value Odds Ratio 95% C1
beta coefficient Estimate
coefficient
Intercept -5.97 -2.32 <0.0001
Male sex -1.03 -0.15 0.67 0.864 0.438-1.701
History of PONV 1.14 0.91 <0.0001 2.480 1.703-3.610
Smoker -0.42 -0.002 0.99 0.997 0.578-1.722
Age -0.14 -0.22 0.002 0.801 0.697-0.922
Duration of surgery 0.46 0.25 0.007 1.280 1.071-1.531
Primary anesthesia = GA 2.36 1.28 <0.0001 3.583 1.941-6.613
Breast plastics 1.90 -0.085 0.82 0.918 0.449-1.877
Gyn surgery, but not 1.20 0.20 0.32 1.220 0.822-1.811
D&C
Table 8: Beta coefficients and odds ratios for refitted Sinclair model. 95% CI = 95% Confidence Interval.
Results of the experimental model's (EM) performance as compared to the original
Apfel model (OAM), refitted Apfel model (RAM), the simplified Apfel risk score
(SARS), and the refitted Sinclair model (RSM) on the validation data set are shown in
Table 9. AUC for the EM was 0.760, for the OAM was 0.676, for the RAM was
0.659, for the SARS was 0.667, and for the RSM was 0.718. ROC curves for each
model are shown in Figure 13.
Pair-wise discrimination comparison of models is shown in Table 10. Statistically
significant differences (p<0.05) in AUC were noted between the EM and all other
models, RAM & RSM, and SARS & RSM.
Calibration, as indicated by goodness of fit by the Hosmer-Lemeshow X2 test, is
shown in Table 9. All models, except the OAM, appeared to have good calibration
for BWH ambulatory surgery data as indicated by a p value of greater than 0.05.
Model AUC for 95% CI for HL X2  HL (p)
test set AUC
Experimental Model (EM) 0.760 0.723-0.797 8.8 0.36
Original Apfel Model (OAM) 0.676 0.633-0.718 43.6 <0.0001
Refitted Apfel Model (RAM) 0.659 0.617-0.701 5.1 0.53
Simplified Apfel Risk Score (SARS) 0.667 0.626-0.707 3.0 0.22
Refitted Sinclair Model (RSM) 0.718 0.678-0.759 7.8 0.46
Table 9: Summary of discrimination and calibration performance for each model. AUC = Area Under
Receiver Operating Characteristic Curve. 95% CI = 95% Confidence Interval. HL X2 = Hosmer-
Lemeshow Chi-Square. HL (p) = Hosmer-Lemeshow probability > Chi-Square value.
Model Experimental Original Apfel Refitted Apfel Refitted Sinclair
Model (EM) Model (OAM) Model (RAM) Model (RSM)
diff p diff p diff p diff p
Experimental
Model (EM)
Original Apfel 0.084 0.0001
Model (OAM)
Refitted Apfel 0.101 <0.0001 0.017 0.32
Model (RAM)
Simplified Apfel 0.093 <0.0001 0.009 0.16 -0.008 0.55
Risk Score (SARS)
Refitted Sinclair 0.041 0.002 -0.043 0.08 -0.059 0.01 -0.052 0.03
Model (RSM)
Table io: Pair-wise discrimination comparison of models. diff = AUC difference. p = p value of
difference.
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Figure 13: ROC curves for various models evaluated on the test dataset.
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Figure 14: Calibration curves for models evaluated on the test dataset.
5.2 Study of electronic feedback to physicians
Nine attending level anesthesiologists were enrolled in the study. Of these, five
received feedback and four were in the control group that did not receive any
feedback. Data on 474 ambulatory surgery patients the nine physicians treated were
also collected over the course of eight months.
All nine subjects completed surveys at beginning of study. Seven completed surveys
at the end of the study; two of the original nine subjects could not be contacted as
they were no longer working at the hospital. Pre-intervention, 78% stated that they
rarely or never received feedback with an average Likert score of 2.00+0.71. All
indicated that they would be willing to change their practice based on feedback. They
....... . .. ...
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wanted this feedback mainly from patients, nurses, and computer systems although
they would also accept it from other anesthesiologists. Most anesthesiologists
underestimated their patients' rate of PONV. The absolute difference was 21+16%
from their actual rate.
Of the five people who received feedback e-mails, four looked at the web site at least
once and responded to more than 25% of the e-mails. They always logged in using
the link in the e-mail, although they were allowed to log in directly to the web site.
Physicians treating more patients logged in more often.
Subjects spent a total of 4.7+2.7 min on website. They spent an average of 0.6+0.7
min viewing their practices and 0.7+0.9 min viewing their patients' outcomes.
Subjects spent the most time on viewing literature guidelines and examining the
PONV risk calculator; they spent 1.8+2.2 min viewing this section of the web site
(Table 11).
Section Time spent
(min)
Physician practices 0.6±0.7
Patient outcomes 0.7±0.9
Literature guidelines, PONV risk calculator 1.8±2.2
Total time 4.7±2.7
Table 11: Time spent by physicians on web site.
Post-intervention, 57% stated that they rarely or never received feedback with an
increase in the Likert score of 2.43±0.53. Most still wanted more feedback.
However, there was no statistically significant difference between pre- and post-
intervention responses.
No significant difference in practice change was observed between groups. Absolute
differences pre- and post-intervention for each recommended best practice were
calculated for the control group and intervention group. For each practice, no
significant difference was noted between groups (Table 12).
Practice Pre/post change Pre/post change
in control group in intervention
(%) group (0 )
No prophylactic anti-emetics (AE) in low risk 12 9
patients
2+ AE, no ondansetron in medium risk patients 16 -31
3+ AE in high risk patients 4 2
3+ AE in extremely high risk patients -1 0
Fentanyl <= 100 mcg IV in high risk patients 12 10
Fentanyl <= 100 mcg IV in extremely high risk 13 10
patients
No NO in high risk patients -19 -3
No NO in extremely high risk patients -17 -5
No inhalational agent in extremely high risk 0 0
patients
Table 12: Absolute change in number of practices complied with pre- and post- intervention.
Follow-up interviews querying for subjects' impressions of the electronic feedback,
the web site, and their reasons for not changing practice indicated several issues.
Many of the subjects thought viewing the web site took too much time and they were
too busy to use it on a regular basis. They felt they did not know where to look on the
web site to access information they wanted or the web site did not provide them with
the information they wanted. Some felt that residents often made decisions when
they were not around and, therefore, felt they were not always in control of practice.
One subject disagreed with the guidelines.
6 Discussion
6.1 PONV risk models
Preliminary analysis indicated that published models would not work for purposes of
this project. Their performance on data from BWH ambulatory surgery patients was
poor. Also, the models could not be used for the education of physicians because
they did not contain certain predictors. Therefore, data collected at BWH was used to
create a new PONV risk prediction model. This experimental model was tested
against several popular models and showed improved performance. A logistic
regression model was used even though other methods of machine learning may have
resulted in better predictive models. Physicians are familiar with logistic regression
models and the concept of "odds ratios" to determine how much of an effect a
variable has on the outcome. Furthermore, other models result in "black box"
formulas such that they often cannot be used for teaching purposes.
6.1.1 Experimental model developed
In our experimental model, history of PONV, history of motion sickness, age,
duration of surgery, type of surgery, intraoperative fentanyl dose,
intraoperative dexamethasone use, intraoperative ondansetron use, type of
anesthetic performed, and maximum pain score postoperatively were
determined to be independent predictors of PONV. Inclusion of these
variables is consistent with published studies as well as the other models.
One of the strongest predictors of PONV was the patient's history of prior
PONV (odds ratio of 2.65). Prior history of motion sickness resulted in a 1.5
increased risk of PONV. An increase in one decade of age resulted in slightly
decreased risk of PONV whereas longer duration of surgery increased the risk
of PONV.
Female gender did not appear in our model, even though female gender has
been well demonstrated as an important predictor of PONV (Cohen, et al.,
1994). This may be due to the composition of the data set such that 88% of
patients were female. With such a large percentage of female patients,
differentiation of risk between male and female patients may be difficult and
the risk may be incorporated into the baseline risk.
Several types of surgery found to have significant effect on PONV. Of these,
laparoscopic cholecystectomy increased the risk of PONV the greatest, with
an odds ratio of 3.2. Pelviscopy also increased risk and this is consistent with
literature (Gan, 2006).
Anesthetic factors found to have an effect on PONV included: intraoperative
fentanyl dose, type of general anesthetic performed (i.e., IV versus inhalation
induction and N20 use versus no N20 use), intraoperative dexamethasone use,
and intraoperative ondansetron use. Previous models have not differentiated
between intraoperative and postoperative doses of narcotics and most have
focused on long term narcotics such as morphine. Literature is controversial
on whether intraoperative narcotics actually increase risk whereas the most
current literature indicates that postoperative narcotic dose does correlate with
increased risk of PONV. Here, although there is a statistically significant
increase in PONV risk with intraoperative fentanyl use, an odds ratio of 1.002
indicates that risk is not increased greatly and this may not be clinically
significant. Furthermore, our model did not find that postoperative narcotics
are associated with increased risk.
Instead, a patient's postoperative pain was shown to be correlated with the
PONV risk. Here, the higher the maximum pain score (scale of 0-10, with ten
being the worst pain experienced) that a patient reported, the more at risk
he/she was for PONV (odds ratio of 1.1). Although some experts have
hypothesized that postoperative pain is associated with PONV (Chia, et al.,
2002) (Gan, 2006), it has been hard to separate out whether postoperative pain
or postoperative narcotic use is the cause of increased PONV. This is because
when the patient complains of pain postoperatively, he/she is treated with
narcotics.
It is reassuring that the type of anesthetic performed appeared to be associated
with PONV risk in our model. Recent studies indicate that exposure to
inhalation agent increases PONV risk (Apfel, et al., 2002) and many experts
advocate avoidance of inhalation agents for high risk groups (Gan, et al.,
2003) (Gan, 2006). In our model, we were able to differentiate between
different types of general anesthetic techniques that some have postulated may
increase risk but have not proven. For example, our model indicates that an
inhalation induction increases risk almost two-fold over an IV induction with
propofol. Exposure to nitrous oxide also seems to increase risk, but more for
patients who undergo IV induction rather than inhalation induction. This may
be due to the fact that an inhalation induction already increases the risk of
PONV. None of the previously published models break down risk by
anesthetic technique, something that can be controlled by the anesthesiologist.
As expected, prophylactic intraoperative use of dexamethasone and
ondansetron independently reduced risk of PONV. This risk reduction was
similar for each medication and is consistent with the 20-25% risk reduction
quoted in the literature (Apfel, et al., 2004) (Thomas, et al., 2001). Ours is the
first model to incorporate these variables and to demonstrate to physicians the
risk reduction resulting from their use after controlling for confounding
variables. Prophylactic use of scopolamine did not appear in the model. This
may be due to the fact that the outcome of PONV was only recorded for up to
time of discharge whereas scopolamine is thought to have more of an effect
on post-discharge nausea and vomiting. Use of either metoclopramide 10 mg
or metoclopramide IV 20 mg IV was not shown to affect PONV; this result is
consistent with literature that numbers needed to treat to prevent one case of
PONV with metoclopramide are very high (Henzi, et al., 1999).
Intramuscular ephedrine use did not appear in the model either, perhaps due to
the fact that only 4.4% of patients received this treatment and its efficacy
could not be determined with such low numbers of data points.
History of smoking did not appear in our model, even though it is well proven
to be associated with decreased risk of PONV. Like in the case of female
gender, this may be due to the patient population studied. Here, only 10.6%
of patients were smokers and, therefore, the risk associated with being a non-
smoker may be incorporated into the baseline risk rather than an independent
predictor.
6.1.2 Discrimination and calibration
The model developed in this project showed statistically significant improved
discrimination over the original Apfel model, the refitted Apfel score, the
simplified Apfel risk score, and the refitted Sinclair model. The Apfel
models, though often advocated for use because of their simplicity, are clearly
not applicable to the BWH ambulatory surgery patient population and may not
be applicable to other institutions' patients also. It is known that risk
prediction models often do not perform as well at institutions other than the
one where the model was developed. Performance results from this study of
the Apfel models are consistent with results at other validation centers (Apfel,
et al., 1999). Another reason for the Apfel models' poor performance may be
that the original models were developed using data from inpatients rather than
ambulatory surgery patients.
The original Apfel model, the refitted Apfel score, and the simplified Apfel
risk score all performed similarly and there was no statistically significant
difference between their performance. The original Apfel model had worse
calibration than the other two, as was to be expected. The simplified Apfel
risk score had good calibration for data at BWH because it classified patients
into only four quartiles.
The refitted Sinclair model had both good discrimination and calibration on
the BWH data. This can be explained by the fact that it was very similar to
the experimental model developed in the types of variables used. However,
the experimental model contained more detailed variables and contained
predictors that appeared in an aggregated form in the Sinclair model. For
example, the Sinclair model differentiates between patients who had general
anesthesia and those who did not. Our model also considers the contribution
of different techniques used to induce general anesthesia to the overall risk.
This may explain why our model provided better discrimination. It also
allows our model to be used for teaching purposes by demonstrating the
relative risks associated with certain anesthetic techniques.
6.2 Electronic feedback to physicians
Prior to intervention, most attending physicians enrolled in the study indicated that
they rarely or never received feedback. The rest indicated that they followed up on
their patients in the recovery room before the patients were discharged. All indicated
that they would like to receive more feedback about their patients' outcomes. They
even indicated that they would be willing to change their practice based on this
feedback.
Of interest is that anesthesiologists underestimated their patients' rate of PONV by an
absolute difference of 21-16%. This is consistent with some physicians' beliefs that
their patients did not have bad outcomes.
Given these data, it was expected that the anesthesiologists would access the
electronic feedback to learn more about their outcomes, educate themselves on
current literature, and possibly change their practices. Unfortunately, electronic
feedback to attending anesthesiologists did not result in change in practices. This
could be due to several factors.
First, it seems as physicians did not adequately use the site to look up their statistics.
Of the five people who received feedback e-mails, four looked at the web site at least
once. However, overall usage was quite low. Surprisingly, physicians always logged
in using the link in the e-mail and never logged in directly by accessing the web site
URL. This could be due to the fact that the physicians were not compelled enough to
review material on the web site consistently but the e-mail served as a reminder to
view the statistics.
Once on the web site, subjects spent a total of 4.7±2.7 min looking at material on the
site. They spent almost 40% of this time viewing the section on literature guidelines.
This could be due to their trying to familiarize themselves with the guidelines.
Physicians spent an average of 0.6±0.7 min viewing their practices and 0.7±0.9 min
viewing their patients' outcomes.
Another reason for a lack of change in practices could be a lack of time on the
physician's part. Because all charting is paper based at BWH, it would take extra
time for the physician to access the web site and review material. For example, in
order to use the online PONV risk calculator, they would have to find a computer, log
into the computer, log into the web site, and then enter patient history factors to
calculate the risk score. This process could take upwards of two minutes.
Physicians treating more patients logged in more often. These physicians were
specialized ambulatory surgery anesthesiologists and the above fact may indicate
these physician's greater interest in their patients' well-being.
One additional reason for lack of use may have been that the site did not provide them
with the information they wanted. However, extensive feedback and testing was done
during creation of the web site to ensure the users would have easy access to the
information they preferred to see.
Lack of compliance by attending anesthesiologists could also be due to absence of a
requirement for them to use the system. Other studies have employed some
verification and compliance measure, such as reporting of the physician to the
department chairperson for non-compliance or publishing individual physicians'
compliances in public.
Follow-up interviews with the subjects substantiated some of the above reasons for
lack of change in practices by the subjects. Many of the subjects thought viewing the
web site took too much time and they were too busy to use it on a regular basis.
Some indicated that they did not know where to look on the web site to access
information they wanted to see.
One other reason several anesthesiologists provided was that they felt that residents
often made decisions when they were not around and, therefore, felt they were not
always in control of practice. They felt that they should provide residents with the
freedom to decide on a different anesthetic plan or that the residents would give
patients medications without prior discussion with the attending. Some of the
physicians who did not regularly practice ambulatory anesthesia felt that PONV was
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not an important patient outcome that warranted a change in their practice. One
subject disagreed with the guidelines. He indicated that he did not believe that
several of these measures would change the outcome.
The responses of these follow-up interviews provide good insight into the difficulties
of implementing an electronic feedback system. Although most physicians want
feedback on patient outcomes and educational literature, they are less open to a
system that provides protocol based care or appears to dictate patient care. Combined
with the extra work required to use the system since it is not at the "point-of-care," an
electronic system is difficult to implement without a formal requirement or
compliance measure.
7 Conclusions
This study's primary objective was to develop and evaluate a sustainable electronic peri-
operative patient outcomes feedback system for its effectiveness in increasing
anesthesiologist compliance with best care practices. We selected PONV in ambulatory
surgery patients as the best care practice to implement and evaluate for the demonstration
system.
In the process of developing such a system, we instituted an informatics infrastructure at
the BWH Department of Anesthesiology as well as developed and evaluated a new,
improved PONV risk prediction model. This new risk prediction model is the first to
incorporate certain anesthetic practices as predictors. It was developed specifically for
the ambulatory surgery patient population and clearly performs better than existing
models.
The electronic system we developed monitored provider practice of multi-modal PONV
control regimens as well as patient outcomes, and it provided anesthesiologists with
information on their practices and their patients' outcomes. This system was evaluated
through a prospective study examining physician practicing behavior.
Although no significant change in provider practice behavior was noted, examination of
reasons for this lack of change provided useful insight on how to improve compliance
with best practices. In addition to providing physicians with data and guidelines,
compliance should be actively enforced and physicians need to be constantly reminded
about their compliance. Any future system should be integrated into the physician's
workflow and at the "point-of-care" to minimize additional burden on the provider.
Future work will focus on validating the new BWH PONV risk prediction model at
outside institutions and integrating the electronic feedback system into clinicians'
workflow to improve compliance. Other outcomes, such as compliance with
perioperative antibiotic guidelines and beta-blocker therapy, will be examined for
incorporation in risk prediction models as well as for use in future iterations of the
electronic feedback system.
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